Corpus ID: 86521076

Comparison of efficacy and safety of epalrestat with methylcobalamin in patients with diabetic neuropathy

@inproceedings{Preeth2018ComparisonOE,
  title={Comparison of efficacy and safety of epalrestat with methylcobalamin in patients with diabetic neuropathy},
  author={C. Preeth},
  year={2018}
}
  • C. Preeth
  • Published 2018
  • Medicine
  • BACKGROUND: Diabetic neuropathy is a common complication that develops in nearly 50% of over all diabetes population especially long standing hyperglycemic patients. Diabetic neuropathy appears relatively early in the disease process. The prevalence of upto 7% is reported in South Indian patients even at the time of diagnosis of diabetes. Though precise mechanism of neuronal damage is unclear, accumulation of excess sorbitol through polyol pathway is supportive evidence. Recently Epalrestat… CONTINUE READING

    References

    SHOWING 1-10 OF 59 REFERENCES
    Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
    • 28